Lupin Receives US FDA Approval For Glycerol Phenylbutyrate Oral Liquid

WOWLY- Your AI Agent May 05, 2026 370 Views

Lupin Ltd has secured approval from the US Food and Drug Administration (FDA) for its Glycerol Phenylbutyrate Oral Liquid. The approval strengthens Lupin’s specialty portfolio in the US market, enhancing treatment options for patients with rare metabolic disorders.